Information de reference pour ce titreAccession Number: | 00000620-199908780-00026.
|
Author: | ASHLEY, ROBERT A. a; THE SDD CLINICAL RESEARCH TEAM
|
Institution: | CollaGenex Pharmaceuticals, Inc., Newtown, Pennsylvania 18940, USA
|
Title: | Clinical Trials of a Matrix Metalloproteinase Inhibitor in Human Periodontal Disease.[Article]
|
Source: | Annals of the New York Academy of Sciences. 878:335-346, 1999.
|
Abstract: | After demonstration by Golub et al. of the ability of the tetracyclines to inhibit elevated collagenolytic activity in animal models of periodontal diseases, a clinical development program was initiated to demonstrate the potential of a subantimicrobial dose of doxycycline (SDD) to augment and maintain the improvements in clinical parameters of adult periodontitis (AP) afforded by conventional nonsurgical periodontal therapy. Clinical trials were carried out in which a number of different SDD dosing regimens and placebo were compared in patients administered a variety of adjunctive nonsurgical therapies. Measured parameters included levels of collagenase activity in gingival crevicular fluid (GCF) and gingival specimens, clinical attachment levels (cALv), probing pocket depths (PD), bleeding on probing (BOP), and subtraction radiographic measurements of alveolar bone height. When used as an adjunct to either scaling and root planing or supragingival scaling and dental prophylaxis, SDD was shown to reduce collagenase levels in both GCF and gingival biopsies, to augment and maintain cALv gains and PD reductions, to reduce BOP, and to prevent loss of alveolar bone height. These clinical responses arose in the absence of any significant effects on the subgingival microflora and without evidence of an increase in the incidence or severity of adverse reactions relative to the control groups. It is proposed that one of the mechanisms of action of SDD is as an inhibitor of pathologically elevated MMPs, including neutrophil and bone cell collagenases (MMP-8 and MMP-13), which are associated with the host response in chronic AP, and that SDD provides a novel systemic approach to the management of AP.
Copyright 1999 by the New York Academy of Sciences. All rights reserved.
|
References: | 1. Williams, R.C. 1990. Medical progress: periodontal disease. N. Engl. J. Med. 332: 373-382.
2. American Academy of Periodontology. 1997. Treatment of gingivitis and periodontitis. J. Periodontol. 68: 1246-1253.
3. American Academy of Periodontology. 1996. Epidemiology of periodontal diseases. J. Periodontol. 67: 935-945.
4. Golub, L.M., M.E. Ryan & R.C. Williams. 1998. Modulation of the host response in the treatment of periodontitis. Dent. Today 17: 102-109.
5. Golub, L.M., H.M. Lee, G. Lehrer, et al. 1983. Minocycline reduces gingival collagenolytic activity during diabetes; preliminary observations and a proposed new mechanism of action. J. Periodont. Res. 18: 516-524.
6. Golub, L.M., M. Wolff, H.M. Lee, et al. 1985. Further evidence that tetracyclines inhibit collagenase activity in human crevicular fluid and from other mammalian sources. J. Periodont. Res. 20: 12-23.
7. Golub, L.M., S. Ciancio, N.S. Ramamurthy, et al. 1990. Low-dose doxycycline therapy: effect on gingival and crevicular fluid collagenase activity in humans. J. Periodont. Res. 25: 321-330.
8. Golub, L.M., N.S. Ramamurthy, T.F. McNamara, et al. 1991. Tetracyclines inhibit connective tissue breakdown: new therapeutic implications for an old family of drugs. Crit. Rev. Oral Biol. Med. 2: 297-322.
9. Golub, L.M., M. Wolff, S. Roberts, et al. 1994. Treating periodontal diseases by blocking tissue-destructive enzymes. JADA 125: 163-169.
10. Golub, L.M., T. Sorsa, H-M. Lee, et al. 1995. Doxycycline inhibits neutrophil (PMN)-type matrix metalloproteinases in human adult periodontitis gingiva. J. Clin. Periodontol. 22: 100-109.
11. Golub, L.M., H.M. Lee, R.A. Greenwald, et al. 1997. A matrix metalloproteinase inhibitor reduces bone-type collagen degradation fragments and specific collagenases in gingival crevicular fluid during adult periodontitis. Inflammation Res. 46: 310-319.
12. Crout, R.J., H.M. Lee, K. Schroeder K, et al. 1996. The "cyclic" regimen of lowdose doxycycline for adult periodontitis: a preliminary study. J. Periodontol. 67: 506-514.
13. Liang, K.Y. & S.L. Zeger. 1986. Longitudinal data analysis using generalized linear models. Biometrika 73: 13-22.
14. Zeger, S.L. & K.Y. Liang. 1986. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 42: 121-130.
15. Ciancio, S., R. Waite, T. Sipos, et al. 1989. Gingival crevicular fluid collagenolytic activity in diagnosing periodontal disease [abstract]. J. Dent. Res. 68: 334.
16. Golub, L.M., T.F. McNamara, B. Kohut, T. Blieden et al. 1999. Adjunctive treatment with subantimicrobial doses of doxycycline: effects on gingival fluid collagenase activity and attachment loss in adult periodontitis. J. Periodontol. Submitted for publication.
|
Language: | English.
|
Document Type: | Inhibition of Matrix Metalloproteinases Therapeutic Applicationsa: Part VII. Clinical Studies-Dental.
|
Journal Subset: | Clinical Medicine. Behavioral & Social Sciences. Life Sciences. Physical Science & Engineering.
|
ISSN: | 0077-8923
|
NLM Journal Code: | 5nm, 7506858
|
Annotation(s) | |